{"id":"W2557845780","doi":"10.1161/atvbaha.115.303397","title":"Overview of the New Oral Anticoagulants","year":2015,"lang":"en","type":"review","venue":"Arteriosclerosis Thrombosis and Vascular Biology","topic":"Atrial Fibrillation Management and Outcomes","field":"Medicine","cited_by":189,"is_retracted":false,"has_abstract":true,"ca_institutions":"Thrombosis and Atherosclerosis Research Institute","funders":"Canadian Institutes of Health Research; McMaster University; Heart and Stroke Foundation of Canada","keywords":"Rivaroxaban; Apixaban; Edoxaban; Dabigatran; Medicine; Warfarin; Intensive care medicine; Atrial fibrillation; Internal medicine","routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003538966,0.0003144448,0.002478527,0.00009766749,0.0000586333,0.00001748681,0.0001737031,0.0002946623,0.00009165412],"category_scores_gemma":[0.00005249645,0.0001720215,0.0009358965,0.0002788144,0.0001446335,0.00003453403,0.0002639329,0.0001300761,0.00002567199],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00002826573,"about_ca_system_score_gemma":0.0001507216,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00005470797,"about_ca_topic_score_gemma":0.00000936852,"domain_scores_codex":[0.9984661,0.0002459342,0.0005740304,0.0003390897,0.0001590041,0.0002158519],"domain_scores_gemma":[0.9988675,0.00005442481,0.0003394373,0.0005681945,0.00005100152,0.000119475],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.000004127619,0.00005545693,0.08662276,0.01631084,0.005259284,8.537096e-8,0.0001632389,1.155984e-7,0.0002112076,0.003491338,0.007444601,0.880437],"study_design_scores_gemma":[0.0005015561,0.0001018889,0.1418788,0.003121107,0.003090561,7.024463e-7,0.000006574231,0.000001399234,6.410291e-7,0.0000464442,0.8510976,0.0001527044],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.001145736,0.9969304,0.00002159584,0.0004031069,0.0004207232,0.0009000666,0.00002240726,0.00002495434,0.000131018],"genre_scores_gemma":[0.0006514106,0.9986106,0.0001710091,0.0001362963,0.0002737197,0.000003783228,0.00006310452,0.00002998566,0.00006005371],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.8802842,"threshold_uncertainty_score":0.7014831,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.4035057671241771,"score_gpt":0.4533760867029758,"score_spread":0.04987031957879873,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}